In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following Federal advisory committee meetings. 

*Name:*                         National Vaccine Advisory Committee (NVAC).                     

*Times and Dates:*                         9 a.m.-2:45 p.m., February 28, 2000.                     

8:30 a.m.-4:15 p.m., February 29, 2000. 

*Place:*                         Hubert H. Humphrey Building, Room 505A, 200 Independence Avenue, SW, Washington, DC 20201.                     

*Status:*                         Open to the public, limited only by the space available.                     

*Notice:*                         In the interest of security, the Department has instituted stringent procedures for entrance to the Hubert H. Humphrey Building by non-government employees. Thus, persons without a government identification card should plan to arrive at the building each day either between 8 a.m. and 8:30 a.m. or 12:30 p.m. and 1 p.m. Entrance to the meeting at other times during the day cannot be assured.                     

*Purpose:*                         This committee advises and makes recommendations to the Director of the National Vaccine Program on matters related to the Program responsibilities.                     

*Matters to be Discussed:*                         Agenda items will include: an update on the National Vaccine Program Office (NVPO) activities; an update on Unmet Needs Funding; an update on Pandemic Planning; Global Plan of Action for Laboratory Containment of Poliovirus; an update on Polio Eradication; Global Vaccines—White House Initiatives; Emerging Issues in Vaccine Safety; Vaccine Safety and Communication Subcommittee Report; Immunization Coverage Subcommittee Report; Future Vaccines Subcommittee Report; update from the Office of the Assistant Secretary for Health and Surgeon General; Healthy People 2010-Update on Vaccines; Annual Report on the Vaccine Injury Compensation Program; ACIP Annual Report; Budget Status on 317, CBER, Pandemic Influenza and Vaccine Safety Implementation Plan; and an update on Immunization Registries.                     

*Name:*                         Subcommittee on Future Vaccines.                     

*Time and Date:*                         2:45 p.m.-5:00 p.m., February 28, 2000.                     

*Place:*                         Hubert H. Humphrey Building, Room 305A, 200 Independence Avenue, SW, Washington, DC 20201.                     

*Status:*                         Open to the public, limited only by the space available.                     

*Purpose:*                         This subcommittee develops policy options and guides national activities that lead to accelerated development, licensure, and the best use of new vaccines in the simplest possible immunization schedules.                     

*Matters to be Discussed:*                         Agenda items will include discussions on the Institute of Medicine Report “Vaccines for the 21st Century”; CMV Workshop planning; Vaccines for special populations; and Vaccines for chronic diseases.                     

*Name:*                         Subcommittee on Immunization Coverage.                     

*Time and Date:*                         2:45 p.m.-5 p.m., February 28, 2000.                     

*Place:*                         Hubert H. Humphrey Building, Room 505A, 200 Independence Avenue, SW, Washington, DC 20201.                     

*Status:*                         Open to the public, limited only by the space available.                     

*Purpose:*                         This subcommittee will identify and propose solutions that provide a multifaceted and holistic approach to reducing barriers that result in low immunization coverage for children.                     

*Matters to be Discussed:*                         Agenda items will include updates on the Working Group on Adult Immunization Standards; the implementation of NVAC's recommendations on Adult Immunization; the process for Strategies to Sustain Success paper; discussions of Philosophical Exemptions; and discussions on Adolescent Immunization.                     

*Name:*                         Subcommittee on Vaccine Safety and Communication.                     

*Time and Date:*                         2:45 p.m.-5 p.m., February 28, 2000.                     

*Place:*                         Hubert H. Humphrey Building, Room 325A, 200 Independence Avenue, SW, Washington, DC 20201.                     

*Status:*                         Open to the public, limited only by the space available.                     

*Purpose:*                         This subcommittee reviews issues relevant to vaccine safety and adverse reactions to vaccines.                     

*Matters to be Discussed:*                         Plans for NVAC Workshop on Risk Communication; Plans for a Workshop on Surveillance for Rare Events; update on Pediatric Standards of Immunization; update on Rotavirus Vaccine.                     

Agenda items are subject to change as priorities dictate. 

# FOR FURTHER INFORMATION: 

Gloria Sagar, Committee Management Specialist, NVPO, CDC, 1600 Clifton Road, NE, M/S D-66, Atlanta, Georgia 30333, telephone 404/687-6672. 

                        The Director, Management Analysis and Services Office, has been delegated the authority to sign                         **Federal Register**                         notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.                     

Dated: February 2, 2000.

Carolyn J. Russell, 

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. 

[FR Doc. 00-2900 Filed 2-8-00; 8:45 am] 

BILLING CODE 4163-18-P